http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2696937-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79ae6dd5bafbd2dd69035367385d754c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-16
filingDate 2018-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_632035740ba0d2e58d59dd8b7a48eef1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95a53ba2be66a9add557f23b2ecc1034
publicationDate 2019-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2696937-C1
titleOfInvention Method for determination of autonomous nervous system links balance disorders in patients with ventricular arrhythmia caused by psychoemotional factors, without structural pathology of heart
abstract FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to cardiology, and can be used to assess participation of autonomous nervous system (ANS) in the genesis of ventricular arrhythmia (VA) caused by psychoemotional factors in patients without a structural pathology of the heart. Mental tests (MT) are carried out: a mental Stroop test (MST), an anger return (AR), an arithmetic count (AC), a conversation on the disease (CD). If observing the decrease or disappearance of ventricular ectopic complexes (VEC) in at least one of the tests, as well as the increase or appearance of the VEC when performing the AC and/or CD tests, the increase in ANS parasympathetic activity is stated. If VEC appears or increases in the AR test, an increase in ANS sympathetic activity is judged. If VEC appears or increases during MST, both sympathetic and parasympathetic ANS activity is stated.EFFECT: method enables simple and safe assessment of the contribution of various ANS sections to arrhythmogenesis in the patients with VA caused by psychoemotional factors, without the structural pathology of the heart, to determine both the management approach and the choice of antiarrhythmic drugs by evaluating the complex of the most significant mental tests.1 cl, 3 tbl, 3 ex
priorityDate 2018-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2099004-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID66000
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID66000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592713
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107841

Total number of triples: 18.